
Hope A. Robinson
Examiner (ID: 16251, Phone: (571)272-0957 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1653, 1652, 1656 |
| Total Applications | 1881 |
| Issued Applications | 1007 |
| Pending Applications | 292 |
| Abandoned Applications | 622 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7710169
[patent_doc_number] => 20120003204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'COMPOSITION CONTAINING ARAZYME FOR THE PREVENTION AND TREATMENT OF CANDER'
[patent_app_type] => utility
[patent_app_number] => 13/225317
[patent_app_country] => US
[patent_app_date] => 2011-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9685
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13225317
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/225317 | Composition containing arazyme for the prevention and treatment of cancer | Sep 1, 2011 | Issued |
Array
(
[id] => 7808194
[patent_doc_number] => 20120059148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'NON-NATURALLY OCCURRING LIPOPROTEIN PARTICLE'
[patent_app_type] => utility
[patent_app_number] => 13/214862
[patent_app_country] => US
[patent_app_date] => 2011-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 12984
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20120059148.pdf
[firstpage_image] =>[orig_patent_app_number] => 13214862
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/214862 | NON-NATURALLY OCCURRING LIPOPROTEIN PARTICLE | Aug 21, 2011 | Abandoned |
Array
(
[id] => 8430858
[patent_doc_number] => 20120252732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'ALBUMIN FUSION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/212879
[patent_app_country] => US
[patent_app_date] => 2011-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 115829
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212879
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/212879 | ALBUMIN FUSION PROTEINS | Aug 17, 2011 | Abandoned |
Array
(
[id] => 17156443
[patent_doc_number] => 20210317494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Liquor And Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 13/814912
[patent_app_country] => US
[patent_app_date] => 2011-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62679
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13814912
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/814912 | Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Liquor And Uses Thereof | Aug 4, 2011 | Abandoned |
Array
(
[id] => 10857775
[patent_doc_number] => 08883970
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-11
[patent_title] => 'Alpha-amylase variants'
[patent_app_type] => utility
[patent_app_number] => 13/187014
[patent_app_country] => US
[patent_app_date] => 2011-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 86772
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13187014
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/187014 | Alpha-amylase variants | Jul 19, 2011 | Issued |
Array
(
[id] => 9166503
[patent_doc_number] => 08592180
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Botryoccocus braunii triterpene synthase proteins and nucleic acid molecules, and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 13/186185
[patent_app_country] => US
[patent_app_date] => 2011-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 14017
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13186185
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/186185 | Botryoccocus braunii triterpene synthase proteins and nucleic acid molecules, and methods for their use | Jul 18, 2011 | Issued |
Array
(
[id] => 9496724
[patent_doc_number] => 08735540
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-27
[patent_title] => 'Peptides with sequentially arranged streptavidin binding modules'
[patent_app_type] => utility
[patent_app_number] => 13/185070
[patent_app_country] => US
[patent_app_date] => 2011-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 10980
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13185070
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/185070 | Peptides with sequentially arranged streptavidin binding modules | Jul 17, 2011 | Issued |
Array
(
[id] => 9937154
[patent_doc_number] => 08986960
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => 'Microorganisms with extended substrate utilization range'
[patent_app_type] => utility
[patent_app_number] => 13/183638
[patent_app_country] => US
[patent_app_date] => 2011-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 22273
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13183638
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/183638 | Microorganisms with extended substrate utilization range | Jul 14, 2011 | Issued |
Array
(
[id] => 7742141
[patent_doc_number] => 20120020911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'MATRIX COMPOSED OF A NATURALLY-OCCURRING PROTEIN BACKBONE CROSS LINKED BY A SYNTHETIC POLYMER AND METHODS OF GENERATING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/181562
[patent_app_country] => US
[patent_app_date] => 2011-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 29263
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20120020911.pdf
[firstpage_image] =>[orig_patent_app_number] => 13181562
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/181562 | Pegylated fibrinogen precursor molecule | Jul 12, 2011 | Issued |
Array
(
[id] => 12247556
[patent_doc_number] => 09920323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Genetically modified phage and use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/178402
[patent_app_country] => US
[patent_app_date] => 2011-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12993
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13178402
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/178402 | Genetically modified phage and use thereof | Jul 6, 2011 | Issued |
Array
(
[id] => 7567078
[patent_doc_number] => 20110287141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-24
[patent_title] => 'CLONING, EXPRESSION AND USE OF ACID PHOSPHOLIPASES'
[patent_app_type] => utility
[patent_app_number] => 13/171005
[patent_app_country] => US
[patent_app_date] => 2011-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13868
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20110287141.pdf
[firstpage_image] =>[orig_patent_app_number] => 13171005
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/171005 | Phospholipase polypeptide and a DNA encoding same | Jun 27, 2011 | Issued |
Array
(
[id] => 7579903
[patent_doc_number] => 20110293786
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-01
[patent_title] => 'Phospholipase C enzyme'
[patent_app_type] => utility
[patent_app_number] => 13/134964
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12492
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20110293786.pdf
[firstpage_image] =>[orig_patent_app_number] => 13134964
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/134964 | Phospholipase C enzyme | Jun 21, 2011 | Abandoned |
Array
(
[id] => 8566559
[patent_doc_number] => 20120329131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'METHOD FOR INCREASING THE ACTIVITY OF SUPEROXIDE DISMUTASE'
[patent_app_type] => utility
[patent_app_number] => 13/166402
[patent_app_country] => US
[patent_app_date] => 2011-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4016
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13166402
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/166402 | METHOD FOR INCREASING THE ACTIVITY OF SUPEROXIDE DISMUTASE | Jun 21, 2011 | Abandoned |
Array
(
[id] => 7744261
[patent_doc_number] => 20120021985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'ALBUMIN FUSION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/152677
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 128976
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021985.pdf
[firstpage_image] =>[orig_patent_app_number] => 13152677
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/152677 | ALBUMIN FUSION PROTEINS | Jun 2, 2011 | Abandoned |
Array
(
[id] => 9254431
[patent_doc_number] => 08617842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-31
[patent_title] => 'Enzymes for use in enzymatic bleaching of food products'
[patent_app_type] => utility
[patent_app_number] => 13/067476
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13643
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13067476
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/067476 | Enzymes for use in enzymatic bleaching of food products | Jun 2, 2011 | Issued |
Array
(
[id] => 7756697
[patent_doc_number] => 20120028900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'METHOD OF PRODUCING FACTOR VIII PROTEINS BY RECOMBINANT METHODS'
[patent_app_type] => utility
[patent_app_number] => 13/153040
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 27108
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028900.pdf
[firstpage_image] =>[orig_patent_app_number] => 13153040
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/153040 | METHOD OF PRODUCING FACTOR VIII PROTEINS BY RECOMBINANT METHODS | Jun 2, 2011 | Abandoned |
Array
(
[id] => 7510892
[patent_doc_number] => 20110256620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'NUCLEIC ACID ENCODING A SELF-ASSEMBLING SPLIT-FLUORESCENT PROTEIN SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 13/118174
[patent_app_country] => US
[patent_app_date] => 2011-05-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 27800
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256620.pdf
[firstpage_image] =>[orig_patent_app_number] => 13118174
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/118174 | Nucleic acid encoding a self-assembling split-fluorescent protein system | May 26, 2011 | Issued |
Array
(
[id] => 8289285
[patent_doc_number] => 20120177610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins'
[patent_app_type] => utility
[patent_app_number] => 13/114951
[patent_app_country] => US
[patent_app_date] => 2011-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 17658
[patent_no_of_claims] => 111
[patent_no_of_ind_claims] => 83
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13114951
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/114951 | Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins | May 23, 2011 | Abandoned |
Array
(
[id] => 8684431
[patent_doc_number] => 20130052715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-28
[patent_title] => 'METHOD FOR PRODUCING RECOMBINANT THROMBIN'
[patent_app_type] => utility
[patent_app_number] => 13/641844
[patent_app_country] => US
[patent_app_date] => 2011-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5627
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13641844
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/641844 | METHOD FOR PRODUCING RECOMBINANT THROMBIN | Apr 19, 2011 | Abandoned |
Array
(
[id] => 8490057
[patent_doc_number] => 20120289464
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-15
[patent_title] => 'ANGIOGENICALLY EFFECTIVE UNIT DOSE OF FGF-2 AND METHOD OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/088132
[patent_app_country] => US
[patent_app_date] => 2011-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16627
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13088132
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/088132 | Method of treating coronary artery disease FGF-2 | Apr 14, 2011 | Issued |